Literature DB >> 34964868

6. Glycemic Targets: Standards of Medical Care in Diabetes-2022.

Boris Draznin, Vanita R Aroda, George Bakris, Gretchen Benson, Florence M Brown, RaShaye Freeman, Jennifer Green, Elbert Huang, Diana Isaacs, Scott Kahan, Jose Leon, Sarah K Lyons, Anne L Peters, Priya Prahalad, Jane E B Reusch, Deborah Young-Hyman.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34964868     DOI: 10.2337/dc22-S006

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  32 in total

1.  Remote Patient Monitoring in Diabetes: How to Acquire, Manage, and Use All of the Data.

Authors:  Eric L Johnson; Eden Miller
Journal:  Diabetes Spectr       Date:  2022-02-08

2.  Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.

Authors:  Laurel H Messer; Bruce A Buckingham; Fran Cogen; Mark Daniels; Greg Forlenza; Rabab Z Jafri; Nelly Mauras; Andrew Muir; R Paul Wadwa; Perrin C White; Steven J Russell; Edward R Damiano; Firas H El-Khatib; Katrina J Ruedy; Courtney A Balliro; Zoey Li; Martin Chase Marak; Peter Calhoun; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2022-10       Impact factor: 7.337

3.  Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus.

Authors:  Hiroshi Takahashi; Yuka Suganuma; Takayuki Ohno; Rimei Nishimura
Journal:  Diabetol Int       Date:  2022-03-16

Review 4.  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; Vanita R Aroda; Billy S Collins; Robert A Gabbay; Jennifer Green; Nisa M Maruthur; Sylvia E Rosas; Stefano Del Prato; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Tsvetalina Tankova; Apostolos Tsapas; John B Buse
Journal:  Diabetologia       Date:  2022-09-24       Impact factor: 10.460

5.  Individualized Glycemic Goals for Older Adults Are a Moving Target.

Authors:  Scott J Pilla; Zhinous Shahidzadeh Yazdi; Simeon I Taylor
Journal:  Diabetes Care       Date:  2022-05-01       Impact factor: 17.152

6.  Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout.

Authors:  Likang Li; Gregory Y H Lip; Shuai Li; Jonathan D Adachi; Lehana Thabane; Guowei Li
Journal:  Cardiovasc Diabetol       Date:  2022-07-15       Impact factor: 8.949

7.  Effects of glycemic traits on left ventricular structure and function: a mendelian randomization study.

Authors:  Sizhi Ai; Xiaoyu Wang; Shanshan Wang; Yilin Zhao; Shuxun Guo; Guohua Li; Zhigang Chen; Fei Lin; Sheng Guo; Yan Li; Jihui Zhang; Guoan Zhao
Journal:  Cardiovasc Diabetol       Date:  2022-06-17       Impact factor: 8.949

8.  Large-Scale Data Analysis for Glucose Variability Outcomes with Open-Source Automated Insulin Delivery Systems.

Authors:  Arsalan Shahid; Dana M Lewis
Journal:  Nutrients       Date:  2022-05-02       Impact factor: 6.706

Review 9.  Diabetes: how to manage diabetic peripheral neuropathy.

Authors:  Megha Gandhi; Emily Fargo; Lalita Prasad-Reddy; Katherine M Mahoney; Diana Isaacs
Journal:  Drugs Context       Date:  2022-06-14

10.  Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial.

Authors:  Juan Pablo Frias; JaeDuk Choi; Julio Rosenstock; Luiza Popescu; Elisabeth Niemoeller; Isabel Muehlen-Bartmer; Seungjae Baek
Journal:  Diabetes Care       Date:  2022-07-07       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.